US Broker Ratings

QuidelOrtho Corporation (QDEL) Investor Outlook: Exploring a Potential 56% Upside

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector, operates within the medical devices industry. Headquartered in San Diego, California, QuidelOrtho provides cutting-edge diagnostic testing solutions through its..

NovoCure Limited (NVCR) Stock Analysis: Potential 132% Upside as Innovative Cancer Treatments Drive Growth

Investors eyeing the healthcare sector may find NovoCure Limited (NASDAQ: NVCR) a compelling prospect, especially given its potential upside of 132.37%. As a key player in the medical devices industry,..

Disc Medicine, Inc. (IRON) Stock Analysis: A Look at the 67.86% Potential Upside in Biotech Innovation

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, has been capturing investor attention with its robust pipeline of innovative treatments for serious hematologic diseases. As the company continues to..

Alvotech (ALVO) Stock Analysis: Unveiling a 110% Upside Potential in the Biosimilar Market

Alvotech (NASDAQ: ALVO) stands as a notable player in the healthcare sector, specializing in the development and manufacturing of biosimilar medicines. Based in Luxembourg, this company is making waves in..

Addus HomeCare Corporation (ADUS) Stock Analysis: 20.72% Upside Potential Fuels Investor Interest

Addus HomeCare Corporation (NASDAQ: ADUS) stands as a compelling player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $2.15 billion, Addus has..

Metsera, Inc. (MTSR) Stock Analysis: A Biotechnology Disruptor with a 75.92% Potential Upside

Metsera, Inc. (NASDAQ: MTSR), a burgeoning player in the biotechnology sector, is capturing significant attention with its promising pipeline of treatments for obesity and related conditions. Based in New York..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Navigating Growth Challenges with Promising CNS Treatments

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical company headquartered in Rockville, Maryland, continues to capture investor attention as it navigates the complex landscape of central nervous system (CNS) treatments. With..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 49% Potential Upside for Investors

UFP Technologies, Inc. (UFPT) is making waves in the healthcare sector, particularly in the medical devices industry, with its innovative solutions. Based in Newburyport, Massachusetts, the company has carved a..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: A 41.93% Upside Potential in the Biotech Sector

MoonLake Immunotherapeutics (Nasdaq: MLTX) has captured the attention of investors with its promising pipeline in the competitive biotechnology sector. Based in Zug, Switzerland, this clinical-stage biotech firm is on the..

LivaNova PLC (LIVN) Stock Analysis: Forecasting a 15% Upside Potential in the Healthcare Sector

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, specifically within the medical devices industry, presents a compelling opportunity for investors seeking exposure to innovative medical technologies. Headquartered..

Catalyst Pharmaceuticals (CPRX) Stock Analysis: Exploring a 66% Potential Upside in Biotech

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) stands out in the biotechnology sector with an impressive trajectory of developing and commercializing treatments for rare diseases. As an investor, understanding the company’s current..

Galapagos NV (GLPG) Stock Analysis: Navigating a -18.96% Potential Downside Amid Biotech Uncertainties

Galapagos NV (NASDAQ: GLPG), headquartered in Mechelen, Belgium, draws investor attention within the dynamic biotechnology sector, focusing on groundbreaking medicines in oncology and immunology. With a market capitalization of $2.12..

ICU Medical, Inc. (ICUI): Analyzing the 40% Potential Upside Amidst Market Challenges

ICU Medical, Inc. (NASDAQ: ICUI), a key player in the medical instruments and supplies industry, is drawing considerable attention from investors due to its promising potential upside of 40.29%. As..

Crinetics Pharmaceuticals, Inc. (CRNX) Investor Outlook: Unpacking the 130% Potential Upside

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) has emerged as a notable player in the biotechnology sector with its focus on developing novel therapies for rare endocrine diseases and endocrine-related tumors. As..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Unpacking a 42% Potential Upside with Promising Biotech Innovations

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) has positioned itself as an intriguing player in the biotechnology sector, particularly within the eye care segment. With its focus on developing therapeutic candidates for..

NewAmsterdam Pharma (NAMS) Stock Analysis: Exploring a 62.76% Potential Upside in Biotech

Investors seeking opportunities in the biotechnology sector might want to turn their attention to NewAmsterdam Pharma Company N.V. (NAMS). With its headquarters in Naarden, Netherlands, NewAmsterdam Pharma is carving out..

Organon & Co. (OGN) Stock Analysis: Unlocking a 45.33% Potential Upside Amidst Market Challenges

Organon & Co. (NYSE: OGN), a key player in the healthcare sector focusing on prescription therapies and medical devices, presents a compelling opportunity for investors despite recent challenges. With a..

Ardent Health, Inc. (ARDT) Stock Analysis: Healthcare Giant with a 51.87% Potential Upside

Ardent Health, Inc. (ARDT) is commanding attention in the healthcare sector with its extensive network of hospitals and clinics across the United States. Specializing in a diverse array of services,..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: A Biotech Gem with 115% Upside Potential

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a key player in the biotechnology sector, presents a compelling opportunity for investors seeking exposure to the healthcare industry’s cutting-edge treatments for rare diseases. With..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a Potential 44.03% Upside in the Healthcare Sector

Investors in the healthcare sector might want to keep a close eye on Perrigo Company plc (NYSE: PRGO), a renowned player in the drug manufacturing industry specializing in both specialty..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds